Patent Yard Sign in
Expired Canadian patentCanada

Lancet blade designed for reduced pain

CA 2115197 C · Owner: Becton, Dickinson And Company · Inventors: Burns, James A.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A lancet assembly having a blade designed for reduced pain that is used for piercing a patient's skin to cause capillary blood to flow for collection and testing. The blade has a shear percentage greater than conventional lancet blades to provide additional cutting action when the blade is being inserted into a puncture wound and a blade width smaller than conventional lancet blades. Reduced width and increasedshear percentage result in reduced skin tear and penetration force which therefore, causes less pain to the patient during skin penetration.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed February 8, 1994 and granted April 20, 1999. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 8, 2014.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 8, 2016.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledFebruary 8, 1994
GrantedApril 20, 1999
Term endedFebruary 8, 2014
Patent numberCA 2115197 C
Classification (IPC)A61B17/34 +1 more

Timeline

Timeline From CIPO dates

1995199719992001200320052007200920112013Application filedFeb 8, 1994Patent grantedApril 20, 1999Term endedFeb 8, 2014

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.